TriSalus Life Sciences In... (TLSI)
NASDAQ: TLSI
· Real-Time Price · USD
4.61
0.73 (18.81%)
At close: Aug 15, 2025, 3:59 PM
4.64
0.65%
After-hours: Aug 15, 2025, 05:46 PM EDT
TriSalus Life Sciences Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -8.29M | -10.38M | -10.11M | -2.4M | -4.33M | -13.22M | -35.51M | -1.48M | -13.97M | -8.27M | -22.54M | 659.46K | 2.39M | -7.87M | 2.9M | 1.86M | 378.87K | -372.03K |
Depreciation & Amortization | 165K | 172K | 371K | 169K | 207K | 251K | 202K | 156K | 150K | 184K | -54K | 171K | 6K | 275K | 157K | n/a | n/a | n/a |
Stock-Based Compensation | 1.89M | 1.62M | 1.7M | 1.38M | 1.27M | 1.09M | 1M | 260K | 68K | 74K | 117K | 119K | 70K | 62K | 63K | n/a | n/a | n/a |
Other Working Capital | -1.57M | 455K | 575K | 2.91M | -3.06M | 913K | -218K | 1.05M | 135K | -342K | -1.3M | 274.93K | -408.48K | -1.96M | 460.62K | n/a | n/a | n/a |
Other Non-Cash Items | 299K | 2.48M | 1.87M | -8.87M | -4.19M | 1.5M | 9.79M | -15.96M | 2.72M | 1.47M | 8.31M | -1.28M | -2.7M | -3.51M | -4.04M | -2.67M | -1.16M | 64.04K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | 11.69M | n/a | -145K | -3.29M | 2.47M | n/a | n/a | 3.49M | n/a | n/a | n/a | n/a |
Change in Working Capital | -1.39M | 1.6M | 467K | -1.13M | -6.38M | -483K | 3.98M | -4.63M | 1.95M | -679K | 3.39M | 274.93K | -380.27K | -3.04M | 460.62K | 442.12K | 297.72K | 102.14K |
Operating Cash Flow | -7.32M | -4.5M | -5.71M | -10.85M | -13.42M | -10.87M | -8.85M | -21.66M | -9.23M | -10.51M | -8.31M | -348.58K | -696.75K | -10.59M | -680.92K | -365.14K | -486.21K | -205.85K |
Capital Expenditures | 93K | -754K | -50K | -169K | -60K | -66K | -700K | -421K | -30K | -74K | -272K | -51K | -130K | -399K | -526K | n/a | n/a | n/a |
Cash Acquisitions | n/a | 40K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1M | n/a | n/a | n/a | -1M | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -191.01K | -234.41K | -78.14K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -8.48M | n/a | n/a | 232.37M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | -328K | 7.79M | 1K | -67K | 932K | 287K | 80K | 11K | 60K | n/a | n/a | n/a |
Investing Cash Flow | 93K | -714K | -50K | -169K | -60K | -66K | -700K | -1.11M | -30K | -74K | -272K | 287K | 80K | -399K | 60K | n/a | n/a | n/a |
Debt Repayment | -1K | 9.93M | -19K | -22K | 22.39M | -22K | -22K | -1.07M | -21K | -22K | -127K | n/a | n/a | -1K | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | -20K | n/a | -8.48M | n/a | -232.37M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -1.49M | -520K | 15.6M | 2K | 5K | 7K | 9.7M | 15.05M | 422K | 4.77M | 21K | 200K | 635K | 61K | 544K | n/a | n/a | n/a |
Financial Cash Flow | 20.72M | 9.69M | 2.99M | 5.82M | 25.99M | 3.13M | 43K | 40.25M | 6.4M | 7.93M | 5.91M | 200K | 635K | 60K | 544K | n/a | n/a | n/a |
Net Cash Flow | 13.49M | 4.47M | -2.76M | -5.19M | 12.51M | -7.81M | -9.51M | 17.48M | -2.86M | -2.65M | -2.67M | 138.42K | 18.25K | -10.93M | -76.92K | -365.14K | -486.21K | -205.85K |
Free Cash Flow | -7.23M | -5.25M | -5.76M | -11.02M | -13.48M | -10.93M | -9.55M | -40.6M | -9.26M | -10.58M | -8.58M | -399.58K | -826.75K | -10.99M | -1.21M | -365.14K | -486.21K | -205.85K |